Head and neck squamous cell carcinoma lines produce biologically active angiogenic factors

Oral Oncology

Volumn 36, Issue 1, 2000, Pages 61-66

  Shemirani, B ^a   Crowe, D L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Angiogenesis; Fibroblast growth factor; Squamous cell carcinoma; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANGIOGENESIS INDUCING AGENTS; CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTORS; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOKINES; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033990664     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00052-4     Document Type: Article

References (34)

1. Folkman J. The role of angiogenesis in tumor growth. Sem Cancer Biol. 3:1992;65-71.
2. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
3. Weidner N., Semple J.P., Welch W., Folkman J. Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. N Eng J Med. 324:1991;1-8.
4. Macchiarini P., Fontanini G., Hardin M.J., Squartini F., Angeletti C.A. Relation of neovascularization to metastasis of non small cell lung cancer. Lancet. 340:1992;145-146.
5. Vartanian R.K., Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor proliferation in breast carcinoma. Am J Pathol. 144:1994;1188-1194.
6. Bikfalvi A., Klein S., Pintucci G., Rifkin D.B. Biological roles of fibroblast growth factor 2. Endocr Rev. 18:1997;26-45.
7. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 18:1997;4-25.
8. Moscatelli D., Presta M., Rifkin D.B. Purification of a factor from human placenta that stimulates endothelial cell protease production, DNA synthesis, and migration. Proc Natl Acad Sci USA. 83:1986;2091-2095.
9. Keegan K., Johnson D.E., Williams L.T., Hayman M.J. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci USA. 88:1991;1095-1099.
10. Partanen J., Makela T.P., Eerola E., Korhonen J., Hirvonen H., Claesson-Welch L., Alitalo K. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 10:1991;1347-1354.
11. Rojeli S., Klagsbrun M., Atzmon R., Kurokawa M., Haimovitz A., Fuks Z., Vlodavski I. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells. J Cell Biol. 109:1989;823-831.
12. Park J.E., Keller G.A., Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: deposition into the subepithelial extracellular matrix and bioactivity of ECM bound VEGF. Mol Biol Cell. 4:1993;1317-1326.
13. Liu Y., Cox S.R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in epithelial cells. Identification of a 5′ enhancer. Circ Res. 77:1995;638-643.
14. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia inducible factor 1. Mol Cell Biol. 16:1996;4604-4613.
15. Pepper M.S., Ferrara N., Orci L., Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Comm. 189:1992;824-831.
16. 165) stimulates angiogenesis in the rabbit cornea. In Vivo. 8:1995;961-965.
17. Mustonen T., Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol. 129:1995;895-898.
18. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.L., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
19. Shalaby F., Ho J., Stanford W.L., Fischer K.D., Schuh A.C., Schwartz L., Bernstein A., Rossant J. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 89:1997;981-990.
20. Maeda K., Chung Y.S., Ogawa Y., Takatsuka S., Kang S.M., Ogawa M., Sawada T., Sowa M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 77:1996;858-863.
21. Oku T., Tjuvajev J.G., Miyagawa T., Sasajima T., Joshi A., Joshi R., Finn R., Claffey K.P., Blasberg R.G. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. Cancer Res. 58:1998;4185-4192.
22. Borgstrom P., Hillan K.J., Sriramarao P., Ferrara N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibodies: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res. 56:1996;4032-4039.
23. Roberts W.G., Palade G. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 108:1995;2369-2379.
24. Parkin D.M., Laara E., Muir C.S. Estimates of the worldwide frequency of sixteen major cancers. Int J Cancer. 41:1988;184-197.
25. Hu L., Crowe D.L., Rheinwald J.G., Chambon P., Gudas L.J. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 51:1991;3972-3981.
26. Vo H.P., Lee M.K., Crowe D.L. α2β1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity. Int J Oncol. 13:1998;1127-1134.
27. Seghezzi G., Patel S., Ren C.J., Gualandris A., Pintucci G., Robbins E.S., Shapiro R.L., Galloway A.C., Rifkin D.B., Mignatti P. Fibroblast growth factor 2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol. 141:1998;1659-1673.
28. Gille J., Swerlick R.A., Caughman S.W. Transforming growth factor alpha induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2 dependent DNA binding and transactivation. EMBO J. 16:1997;750-759.
29. Arbiser J.L., Moses M.A., Fernandez C.A., Ghiso N., Cao Y., Klauber N., Frank D., Brownlee M., Flynn E., Parangi S., Byers H.R., Folkman J. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci USA. 94:1997;861-866.
30. Fukumura D., Xavier R., Sugiura T., Chen Y., Park E.C., Lu N., Selig M., Nielsen G., Taksir T., Jain R.K., Seed B. Tumor induction of VEGF promoter activity in stromal cells. Cell. 94:1998;715-725.
31. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshet E. Role of HIF-1α in hypoxia mediated apoptosis, cell proliferation, and tumor angiogenesis. Nature. 394:1998;485-490.
32. Zhong H., Agani F., Baccala A.A., Laughner E., Rioseco-Camacho N., Isaacs W.B., Simons J.W., Semenza G.L. Increased expression of hypoxia inducible factor 1α in rat and human prostate cancer. Cancer Res. 58:1998;5280-5284.
33. Seko Y., Takahashi N., Tobe K., Kadowaki T., Yazaki Y. Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen activated protein kinase (MAPK), and stress activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem Biophys Res Comm. 239:1997;840-844.
34. Tsang D.K., Crowe D.L. The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines. Int J Cancer. 15:1999;519-523.